FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer
The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
May 11, 2026
0
3
The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
May 11, 2026
0
3
New research shows that palliative patients with pancreatic cancer neither live longer nor experience improved quality of life when taking mistletoe extract in addition to standard cancer treatment, compared to placebo. The ...
May 4, 2026
0
3
Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential ...
May 3, 2026
0
29
Scientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer.
May 2, 2026
0
10
Researchers at Trinity College Dublin have published a major new review that brings fresh clarity to one of the deadliest forms of cancer—pancreatic cancer—by mapping how the disease operates at every level. The review is ...
May 1, 2026
0
13
Pancreatic cancer can remain quiet for years, developing undetected before causing symptoms that lead to a diagnosis. Even after a surgeon removes a pancreas tumor, other cells often hide and erupt later. But University of ...
Apr 30, 2026
0
17
Pancreatic cancer remains one of the most difficult cancers to treat, in large part because tumors do not exist in isolation. Instead, they are surrounded by a dense and complex network of blood vessels, connective tissue, ...
Apr 29, 2026
0
7
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The device identifies the biomarker molecule CA19-9, which is associated with the disease, at low concentrations ...
Apr 22, 2026
0
6
After decades of struggling to find a way to treat pancreatic cancer, researchers have developed several promising new drugs that could offer rare hope to patients given this particularly deadly diagnosis.
Apr 22, 2026
0
33
Pancreatic cancer is one of the deadliest cancers and among the hardest to treat, with most patients surviving less than a year after diagnosis. But a new drug developed at Northwestern University may soon help patients live ...
Apr 14, 2026
0
31